Megan Denton-Brown BPharm, FANZCAP (PeriopMed, Surg), Sharon Selvanayakam BPharm, FANZCAP (Edu, Surg), Jane La MClinPharm, Susan Liew MBBS (Hons), FRACS (orth)
{"title":"住院时股骨颈骨折临床护理路径的伙伴药师用药图表","authors":"Megan Denton-Brown BPharm, FANZCAP (PeriopMed, Surg), Sharon Selvanayakam BPharm, FANZCAP (Edu, Surg), Jane La MClinPharm, Susan Liew MBBS (Hons), FRACS (orth)","doi":"10.1002/jppr.70001","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Neck of femur (NOF) fractures are associated with significant morbidity and mortality. Fractured NOF clinical care pathways (CCPs) standardise care; however, the impact of Partnered Pharmacist Medication Charting (PPMC) in this context remains unexplored.</p>\n </section>\n \n <section>\n \n <h3> Aim</h3>\n \n <p>To evaluate pharmacist involvement through PPMC on the proportion of patients initiated on the electronic medical record (EMR) integrated Fractured NOF CCP, at hospital admission.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>A retrospective, pre- and post-intervention study was conducted in the orthopaedic unit of a tertiary-referral health service. Patients ≥65 years with a primary minimal trauma NOF fracture were included. In the intervention, the Fractured NOF CCP could be initiated through PPMC, in addition to usual care. The primary outcome of the study was the proportion of patients initiated on the CCP and secondary outcomes included the proportion of PPMC initiated CCPs and the time to CCP initiation. Ethical approval was granted by the Alfred Hospital Research and Ethics Committee (Reference no: 779/20) and the study conforms to the Australian <i>National statement on ethical conduct in human research</i>.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 127 patients pre-intervention (January–August 2020) and 149 patients post-intervention (January–August 2021) were included. Fractured NOF CCP initiation increased post-intervention (<i>n</i> = 20, 15.7% vs <i>n</i> = 83, 55.7%, p < 0.0001). Emergency department initiation of the CCP was similar (<i>n</i> = 20, 15.7% vs <i>n</i> = 23, 15.4%, p = 0.94); and median (interquartile range [IQR]) time to initiation increased (0.9 h, IQR 0.4–1.9 h vs 3.9 h, IQR 2.0–6.3 h, p = 0.001). Post-intervention, 60 additional patients were initiated on the CCP through ward care components; median time to initiation was 16.4 h, IQR 11.8–20.6 h, and 61 (73.5%) patients were initiated on the CCP via PPMC.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Pharmacist involvement through PPMC significantly increased the proportion of patients initiated on the Fractured NOF CCP at hospital admission. The delay in initiation post-intervention requires further exploration.</p>\n </section>\n </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"55 4","pages":"311-318"},"PeriodicalIF":1.0000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Partnered pharmacist medication charting of the fractured neck of femur clinical care pathway at hospital admission\",\"authors\":\"Megan Denton-Brown BPharm, FANZCAP (PeriopMed, Surg), Sharon Selvanayakam BPharm, FANZCAP (Edu, Surg), Jane La MClinPharm, Susan Liew MBBS (Hons), FRACS (orth)\",\"doi\":\"10.1002/jppr.70001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Neck of femur (NOF) fractures are associated with significant morbidity and mortality. Fractured NOF clinical care pathways (CCPs) standardise care; however, the impact of Partnered Pharmacist Medication Charting (PPMC) in this context remains unexplored.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Aim</h3>\\n \\n <p>To evaluate pharmacist involvement through PPMC on the proportion of patients initiated on the electronic medical record (EMR) integrated Fractured NOF CCP, at hospital admission.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Method</h3>\\n \\n <p>A retrospective, pre- and post-intervention study was conducted in the orthopaedic unit of a tertiary-referral health service. Patients ≥65 years with a primary minimal trauma NOF fracture were included. In the intervention, the Fractured NOF CCP could be initiated through PPMC, in addition to usual care. The primary outcome of the study was the proportion of patients initiated on the CCP and secondary outcomes included the proportion of PPMC initiated CCPs and the time to CCP initiation. Ethical approval was granted by the Alfred Hospital Research and Ethics Committee (Reference no: 779/20) and the study conforms to the Australian <i>National statement on ethical conduct in human research</i>.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>A total of 127 patients pre-intervention (January–August 2020) and 149 patients post-intervention (January–August 2021) were included. Fractured NOF CCP initiation increased post-intervention (<i>n</i> = 20, 15.7% vs <i>n</i> = 83, 55.7%, p < 0.0001). Emergency department initiation of the CCP was similar (<i>n</i> = 20, 15.7% vs <i>n</i> = 23, 15.4%, p = 0.94); and median (interquartile range [IQR]) time to initiation increased (0.9 h, IQR 0.4–1.9 h vs 3.9 h, IQR 2.0–6.3 h, p = 0.001). Post-intervention, 60 additional patients were initiated on the CCP through ward care components; median time to initiation was 16.4 h, IQR 11.8–20.6 h, and 61 (73.5%) patients were initiated on the CCP via PPMC.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Pharmacist involvement through PPMC significantly increased the proportion of patients initiated on the Fractured NOF CCP at hospital admission. The delay in initiation post-intervention requires further exploration.</p>\\n </section>\\n </div>\",\"PeriodicalId\":16795,\"journal\":{\"name\":\"Journal of Pharmacy Practice and Research\",\"volume\":\"55 4\",\"pages\":\"311-318\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacy Practice and Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jppr.70001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Practice and Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jppr.70001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
摘要
背景:股骨颈(NOF)骨折与显著的发病率和死亡率相关。骨折性非骨折临床护理途径(CCPs)标准化护理;然而,合作药剂师药物图表(PPMC)在这方面的影响仍未被探索。目的评价通过PPMC对住院时纳入骨折性非CCP电子病历(EMR)的患者比例的影响。方法对某三级转诊医疗服务骨科进行回顾性、干预前后研究。患者年龄≥65岁,伴有原发性轻度创伤非of骨折。在干预中,除了常规护理外,骨折的非of CCP可以通过PPMC开始。该研究的主要结局是开始CCP的患者比例,次要结局包括PPMC开始CCP的比例和CCP开始的时间。阿尔弗雷德医院研究和伦理委员会(参考编号:779/20)给予了伦理批准,该研究符合澳大利亚国家关于人类研究伦理行为的声明。结果共纳入干预前(2020年1月- 8月)127例,干预后(2021年1月- 8月)149例。干预后骨折性NOF CCP发生率增加(n = 20,15.7% vs n = 83,55.7%, p < 0.0001)。急诊科CCP的起始率相似(n = 20、15.7% vs n = 23、15.4%,p = 0.94);起始时间中位数(四分位数间距[IQR])增加(0.9 h, IQR 0.4-1.9 h vs 3.9 h, IQR 2.0-6.3 h, p = 0.001)。干预后,另外60名患者通过病房护理组成部分开始使用CCP;中位起始时间为16.4 h, IQR为11.8-20.6 h, 61例(73.5%)患者通过PPMC开始CCP治疗。结论药师参与PPMC可显著提高住院时非of CCP骨折患者的比例。干预后启动延迟需要进一步探索。
Partnered pharmacist medication charting of the fractured neck of femur clinical care pathway at hospital admission
Background
Neck of femur (NOF) fractures are associated with significant morbidity and mortality. Fractured NOF clinical care pathways (CCPs) standardise care; however, the impact of Partnered Pharmacist Medication Charting (PPMC) in this context remains unexplored.
Aim
To evaluate pharmacist involvement through PPMC on the proportion of patients initiated on the electronic medical record (EMR) integrated Fractured NOF CCP, at hospital admission.
Method
A retrospective, pre- and post-intervention study was conducted in the orthopaedic unit of a tertiary-referral health service. Patients ≥65 years with a primary minimal trauma NOF fracture were included. In the intervention, the Fractured NOF CCP could be initiated through PPMC, in addition to usual care. The primary outcome of the study was the proportion of patients initiated on the CCP and secondary outcomes included the proportion of PPMC initiated CCPs and the time to CCP initiation. Ethical approval was granted by the Alfred Hospital Research and Ethics Committee (Reference no: 779/20) and the study conforms to the Australian National statement on ethical conduct in human research.
Results
A total of 127 patients pre-intervention (January–August 2020) and 149 patients post-intervention (January–August 2021) were included. Fractured NOF CCP initiation increased post-intervention (n = 20, 15.7% vs n = 83, 55.7%, p < 0.0001). Emergency department initiation of the CCP was similar (n = 20, 15.7% vs n = 23, 15.4%, p = 0.94); and median (interquartile range [IQR]) time to initiation increased (0.9 h, IQR 0.4–1.9 h vs 3.9 h, IQR 2.0–6.3 h, p = 0.001). Post-intervention, 60 additional patients were initiated on the CCP through ward care components; median time to initiation was 16.4 h, IQR 11.8–20.6 h, and 61 (73.5%) patients were initiated on the CCP via PPMC.
Conclusion
Pharmacist involvement through PPMC significantly increased the proportion of patients initiated on the Fractured NOF CCP at hospital admission. The delay in initiation post-intervention requires further exploration.
期刊介绍:
The purpose of this document is to describe the structure, function and operations of the Journal of Pharmacy Practice and Research, the official journal of the Society of Hospital Pharmacists of Australia (SHPA). It is owned, published by and copyrighted to SHPA. However, the Journal is to some extent unique within SHPA in that it ‘…has complete editorial freedom in terms of content and is not under the direction of the Society or its Council in such matters…’. This statement, originally based on a Role Statement for the Editor-in-Chief 1993, is also based on the definition of ‘editorial independence’ from the World Association of Medical Editors and adopted by the International Committee of Medical Journal Editors.